Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Cord Injuries | 4 | 2007 | 311 | 0.380 |
Why?
|
| Adenosine Triphosphate | 2 | 2007 | 287 | 0.320 |
Why?
|
| Urinary Bladder | 3 | 2007 | 242 | 0.320 |
Why?
|
| Spinal Cord | 1 | 2006 | 305 | 0.240 |
Why?
|
| Botulinum Toxins, Type A | 3 | 2007 | 167 | 0.160 |
Why?
|
| Urinary Bladder, Neurogenic | 2 | 2007 | 45 | 0.140 |
Why?
|
| Neurons | 1 | 2006 | 1936 | 0.130 |
Why?
|
| Laparoscopy | 2 | 2009 | 501 | 0.110 |
Why?
|
| Nitric Oxide | 2 | 2007 | 439 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2007 | 1214 | 0.100 |
Why?
|
| Sus scrofa | 2 | 2011 | 122 | 0.100 |
Why?
|
| Hernia, Ventral | 1 | 2011 | 40 | 0.090 |
Why?
|
| Magnetics | 1 | 2011 | 41 | 0.090 |
Why?
|
| Abdominal Wall | 1 | 2011 | 32 | 0.090 |
Why?
|
| Surgical Mesh | 1 | 2011 | 62 | 0.090 |
Why?
|
| Rats | 6 | 2007 | 3654 | 0.090 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2011 | 42 | 0.090 |
Why?
|
| Herniorrhaphy | 1 | 2011 | 80 | 0.090 |
Why?
|
| Suture Techniques | 1 | 2011 | 198 | 0.090 |
Why?
|
| Chronic Disease | 4 | 2007 | 1168 | 0.090 |
Why?
|
| Equipment Failure Analysis | 1 | 2009 | 90 | 0.080 |
Why?
|
| Task Performance and Analysis | 1 | 2009 | 95 | 0.080 |
Why?
|
| Microdialysis | 2 | 2006 | 56 | 0.080 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2009 | 61 | 0.080 |
Why?
|
| Urethra | 1 | 2008 | 83 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 1 | 2008 | 258 | 0.080 |
Why?
|
| Robotics | 1 | 2009 | 106 | 0.080 |
Why?
|
| Anastomosis, Surgical | 1 | 2008 | 169 | 0.080 |
Why?
|
| Neuromuscular Agents | 2 | 2007 | 67 | 0.070 |
Why?
|
| Urothelium | 1 | 2007 | 60 | 0.070 |
Why?
|
| Receptors, Epoprostenol | 1 | 2007 | 14 | 0.070 |
Why?
|
| Muscarinic Agonists | 1 | 2006 | 6 | 0.070 |
Why?
|
| Carbachol | 1 | 2006 | 18 | 0.070 |
Why?
|
| Stimulation, Chemical | 1 | 2006 | 64 | 0.070 |
Why?
|
| Receptors, Purinergic | 1 | 2006 | 16 | 0.070 |
Why?
|
| Atropine | 1 | 2006 | 30 | 0.070 |
Why?
|
| Models, Animal | 1 | 2008 | 464 | 0.070 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2007 | 28 | 0.070 |
Why?
|
| Pressure | 1 | 2006 | 130 | 0.070 |
Why?
|
| Muscarinic Antagonists | 1 | 2006 | 38 | 0.070 |
Why?
|
| Receptors, Cholinergic | 1 | 2006 | 84 | 0.070 |
Why?
|
| Sensation | 1 | 2005 | 58 | 0.060 |
Why?
|
| Neurotoxins | 1 | 2005 | 56 | 0.060 |
Why?
|
| Intestines | 1 | 2008 | 570 | 0.060 |
Why?
|
| Cystitis | 1 | 2005 | 50 | 0.060 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2003 | 65 | 0.050 |
Why?
|
| Cyclic GMP | 1 | 2003 | 92 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2006 | 1325 | 0.050 |
Why?
|
| Animals | 8 | 2011 | 33749 | 0.040 |
Why?
|
| Equipment Design | 2 | 2011 | 601 | 0.040 |
Why?
|
| Muscle Contraction | 2 | 2007 | 186 | 0.030 |
Why?
|
| Female | 6 | 2011 | 65500 | 0.030 |
Why?
|
| Laparoscopes | 1 | 2011 | 3 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2011 | 57 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2003 | 4489 | 0.020 |
Why?
|
| Dissection | 1 | 2011 | 52 | 0.020 |
Why?
|
| Cadaver | 1 | 2011 | 130 | 0.020 |
Why?
|
| Sutures | 1 | 2011 | 67 | 0.020 |
Why?
|
| Time Factors | 2 | 2011 | 6217 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2011 | 256 | 0.020 |
Why?
|
| Hypogastric Plexus | 1 | 2007 | 7 | 0.020 |
Why?
|
| Hypotonic Solutions | 1 | 2007 | 15 | 0.020 |
Why?
|
| Parasympathetic Nervous System | 1 | 2007 | 15 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2007 | 136 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2008 | 332 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2007 | 105 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2007 | 145 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2007 | 348 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2009 | 1388 | 0.020 |
Why?
|
| Administration, Intravesical | 1 | 2005 | 31 | 0.020 |
Why?
|
| Supraoptic Nucleus | 1 | 2003 | 5 | 0.010 |
Why?
|
| Pituitary Gland, Posterior | 1 | 2003 | 6 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 2003 | 65 | 0.010 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2003 | 20 | 0.010 |
Why?
|
| Vasopressins | 1 | 2003 | 43 | 0.010 |
Why?
|
| Guanylate Cyclase | 1 | 2003 | 37 | 0.010 |
Why?
|
| Isotonic Solutions | 1 | 2003 | 35 | 0.010 |
Why?
|
| Dehydration | 1 | 2003 | 37 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2003 | 95 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 2003 | 76 | 0.010 |
Why?
|
| Consciousness | 1 | 2003 | 49 | 0.010 |
Why?
|
| Oxytocin | 1 | 2003 | 70 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2003 | 186 | 0.010 |
Why?
|
| Citrulline | 1 | 2003 | 83 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2830 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2008 | 972 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 572 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 4271 | 0.010 |
Why?
|
| Male | 2 | 2008 | 60082 | 0.010 |
Why?
|
| Humans | 2 | 2011 | 123169 | 0.000 |
Why?
|